BioCryst Pharmaceuticals, Inc. (BCRX)

8.75 +0.85 (+10.76%) USD  |  NASDAQ  |  Feb 27, 16:00
8.71 -0.04 (-0.46%) After-Hours: 20:00
More

BioCryst Pharmaceuticals Repurchase of Capital Stock (Quarterly)

Repurchase of Capital Stock (Quarterly) Chart

View Repurchase of Capital Stock (Quarterly) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Repurchase of Capital Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Repurchase of Capital Stock (Quarterly) Range, Past 5 Years

View Repurchase of Capital Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Repurchase of Capital Stock (Quarterly) Benchmarks

View Repurchase of Capital Stock (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. --
Lantheus Holdings, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade